Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06644742 · ClinicalTrials.gov registry record
PKP2-ACM Natural History Study
A clinical trial of Cardiovascular Diseases and Heart Diseases, sponsored by Rocket Pharmaceuticals.
- Recruiting
- Registry status
- 36
- Enrollment target
- 3
- Study locations
NCT06644742 is a study of Cardiovascular Diseases and Heart Diseases that is actively recruiting participants, run by Rocket Pharmaceuticals. The registered enrollment target is 36 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06644742, a study of Cardiovascular Diseases and Heart Diseases, is actively recruiting participants, sponsored by Rocket Pharmaceuticals.
- RECRUITING
- Registry status
- 36 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this study is to describe the natural history and clinical events for patients who have Arrhythmogenic Cardiomyopathy with Pathogenic Plakophilin-2 Variants (PKP2-ACM) managed with standard of care.
Conditions Studied
Study Locations (3)
Massachusetts
- Boston Children's Hospital - Boston
North Carolina
- Duke University - Durham
Other
- Amsterdam UMC - Amsterdam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2026-03 |
| Est. Completion | 2031-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06644742
The ClinicalTrials.gov registry entry for NCT06644742 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Rocket Pharmaceuticals, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT06644742 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, North Carolina, Other.
Frequently Asked Questions
What is clinical trial NCT06644742 about?
NCT06644742 is a clinical study titled "PKP2-ACM Natural History Study". The goal of this study is to describe the natural history and clinical events for patients who have Arrhythmogenic Cardiomyopathy with Pathogenic Plakophilin-2 Variants (PKP2-ACM) managed with standard of care.
What is the current status of trial NCT06644742?
This trial is currently recruiting. The enrollment target is 36 participants. The study started on 2026-03. Estimated completion is 2031-04.
What conditions does trial NCT06644742 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Heart Diseases, Cardiomyopathies, Genetic Diseases.
Who is sponsoring clinical trial NCT06644742?
This trial is sponsored by Rocket Pharmaceuticals, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06644742 being conducted?
This trial has 3 study locations across Massachusetts, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)
RECRUITING
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.